Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Twist Bioscience Corporation (TWST : NSDQ)
 
 • Company Description   
Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California.

Number of Employees: 923

 
 • Price / Volume Information   
Yesterday's Closing Price: $36.98 Daily Weekly Monthly
20 Day Moving Average: 890,452 shares
Shares Outstanding: 59.92 (millions)
Market Capitalization: $2,215.70 (millions)
Beta: 2.41
52 Week High: $60.90
52 Week Low: $27.12
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 7.34% 4.12%
12 Week -6.38% -18.84%
Year To Date -20.42% -24.82%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
681 GATEWAY BLVD.
-
SOUTH SAN FRANCISCO,CA 94080
USA
ph: 800-719-0671
fax: -
abitting@twistbioscience.com http://www.twistbioscience.com
 
 • General Corporate Information   
Officers
Emily M. Leproust - Chief Executive Officer and Chair of the Board of
Adam Laponis - Chief Financial Officer
Robert F. Werner - Chief Accounting Officer
Nelson C. Chan - Director
Robert Chess - Director

Peer Information
Twist Bioscience Corporation (CORR.)
Twist Bioscience Corporation (RSPI)
Twist Bioscience Corporation (CGXP)
Twist Bioscience Corporation (BGEN)
Twist Bioscience Corporation (GTBP)
Twist Bioscience Corporation (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 90184D100
SIC: 2836
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/01/25
Share - Related Items
Shares Outstanding: 59.92
Most Recent Split Date: (:1)
Beta: 2.41
Market Capitalization: $2,215.70 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.45 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.17 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/01/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 5.01
Price/Cash Flow: -
Price / Sales: 6.37
EPS Growth
vs. Year Ago Period: 16.46%
vs. Previous Quarter: -24.53%
Sales Growth
vs. Year Ago Period: 23.23%
vs. Previous Quarter: 4.60%
ROE
06/30/25 - -
03/31/25 - -33.48
12/31/24 - -32.69
ROA
06/30/25 - -
03/31/25 - -25.34
12/31/24 - -25.25
Current Ratio
06/30/25 - -
03/31/25 - 4.51
12/31/24 - 4.96
Quick Ratio
06/30/25 - -
03/31/25 - 4.24
12/31/24 - 4.62
Operating Margin
06/30/25 - -
03/31/25 - -44.77
12/31/24 - -49.01
Net Margin
06/30/25 - -
03/31/25 - -54.98
12/31/24 - -59.76
Pre-Tax Margin
06/30/25 - -
03/31/25 - -54.87
12/31/24 - -59.60
Book Value
06/30/25 - -
03/31/25 - 7.38
12/31/24 - 7.64
Inventory Turnover
06/30/25 - -
03/31/25 - 7.65
12/31/24 - 6.87
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.03
12/31/24 - 0.03
Debt-to-Capital
06/30/25 - -
03/31/25 - 3.30
12/31/24 - 3.19
 

Powered by Zacks Investment Research ©